-
1
-
-
0038190924
-
Development of an efficient "substratetrapping" mutant of Src homology phosphotyrosine phosphatase 2 and identification of the epidermal growth factor receptor, Gab1, and three other proteins as target substrates
-
Agazie, Y.M., and M.J. Hayman. 2003. Development of an efficient "substratetrapping" mutant of Src homology phosphotyrosine phosphatase 2 and identification of the epidermal growth factor receptor, Gab1, and three other proteins as target substrates. J. Biol. Chem. 278:13952-13958. http://dx.doi.org/10.1074/jbc.M210670200
-
(2003)
J. Biol. Chem.
, vol.278
, pp. 13952-13958
-
-
Agazie, Y.M.1
Hayman, M.J.2
-
2
-
-
46249129455
-
Extracellular point mutations in FGFR2 elicit unexpected changes in intracellular signalling
-
Ahmed, Z., A.C. Schüller, K. Suhling, C. Tregidgo, and J.E. Ladbury. 2008. Extracellular point mutations in FGFR2 elicit unexpected changes in intracellular signalling. Biochem. J. 413:37-49. http://dx.doi.org/10.1042/BJ20071594
-
(2008)
Biochem. J.
, vol.413
, pp. 37-49
-
-
Ahmed, Z.1
Schüller, A.C.2
Suhling, K.3
Tregidgo, C.4
Ladbury, J.E.5
-
3
-
-
70350001098
-
Direct binding of Grb2 SH3 domain to FGFR2 regulates SHP2 function
-
Ahmed, Z., R. George, C.C. Lin, K.M. Suen, J.A. Levitt, K. Suhling, and J.E. Ladbury. 2010. Direct binding of Grb2 SH3 domain to FGFR2 regulates SHP2 function. Cell. Signal. 22:23-33. http://dx.doi.org/10.1016/j.cellsig.2009.08.011
-
(2010)
Cell. Signal.
, vol.22
, pp. 23-33
-
-
Ahmed, Z.1
George, R.2
Lin, C.C.3
Suen, K.M.4
Levitt, J.A.5
Suhling, K.6
Ladbury, J.E.7
-
4
-
-
0142211311
-
Tyrosyl phosphorylation of Shp2 is required for normal ERK activation in response to some, but not all, growth factors
-
Araki, T., H. Nawa, and B.G. Neel. 2003. Tyrosyl phosphorylation of Shp2 is required for normal ERK activation in response to some, but not all, growth factors. J. Biol. Chem. 278:41677-41684. http://dx.doi.org/10.1074/jbc.M306461200
-
(2003)
J. Biol. Chem.
, vol.278
, pp. 41677-41684
-
-
Araki, T.1
Nawa, H.2
Neel, B.G.3
-
5
-
-
0032521428
-
Revealing mechanisms for SH2 domain mediated regulation of the protein tyrosine phosphatase SHP-2
-
Barford, D., and B.G. Neel. 1998. Revealing mechanisms for SH2 domain mediated regulation of the protein tyrosine phosphatase SHP-2. Structure. 6:249-254. http://dx.doi.org/10.1016/S0969-2126(98)00027-6
-
(1998)
Structure.
, vol.6
, pp. 249-254
-
-
Barford, D.1
Neel, B.G.2
-
6
-
-
10644268691
-
Substrate-trapping techniques in the identification of cellular PTP targets
-
Blanchetot, C., M. Chagnon, N. Dubé, M. Hallé, and M.L. Tremblay. 2005. Substrate-trapping techniques in the identification of cellular PTP targets. Methods. 35:44-53. http://dx.doi.org/10.1016/j.ymeth.2004.07.007
-
(2005)
Methods.
, vol.35
, pp. 44-53
-
-
Blanchetot, C.1
Chagnon, M.2
Dubé, N.3
Hallé, M.4
Tremblay, M.L.5
-
7
-
-
77949277517
-
FGFR2 mutations are rare across histologic subtypes of ovarian cancer
-
Byron, S.A., M.G. Gartside, C.L. Wellens, P.J. Goodfellow, M.J. Birrer, I.G. Campbell, and P.M. Pollock. 2010. FGFR2 mutations are rare across histologic subtypes of ovarian cancer. Gynecol. Oncol. 117:125-129. http://dx.doi.org/10.1016/j.ygyno.2009.12.002
-
(2010)
Gynecol. Oncol.
, vol.117
, pp. 125-129
-
-
Byron, S.A.1
Gartside, M.G.2
Wellens, C.L.3
Goodfellow, P.J.4
Birrer, M.J.5
Campbell, I.G.6
Pollock, P.M.7
-
8
-
-
40949090037
-
Involvement of fibroblast growth factor receptor 2 isoform switching in mammary oncogenesis
-
Cha, J.Y., Q.T. Lambert, G.W. Reuther, and C.J. Der. 2008. Involvement of fibroblast growth factor receptor 2 isoform switching in mammary oncogenesis. Mol. Cancer Res. 6:435-445. http://dx.doi.org/10.1158/1541-7786.MCR-07-0187
-
(2008)
Mol. Cancer Res.
, vol.6
, pp. 435-445
-
-
Cha, J.Y.1
Lambert, Q.T.2
Reuther, G.W.3
Der, C.J.4
-
9
-
-
65249140043
-
Aberrant receptor internalization and enhanced FRS2-dependent signaling contribute to the transforming activity of the fibroblast growth factor receptor 2 IIIb C3 isoform
-
Cha, J.Y., S. Maddileti, N. Mitin, T.K. Harden, and C.J. Der. 2009. Aberrant receptor internalization and enhanced FRS2-dependent signaling contribute to the transforming activity of the fibroblast growth factor receptor 2 IIIb C3 isoform. J. Biol. Chem. 284:6227-6240. http://dx.doi.org/10.1074/jbc.M803998200
-
(2009)
J. Biol. Chem.
, vol.284
, pp. 6227-6240
-
-
Cha, J.Y.1
Maddileti, S.2
Mitin, N.3
Harden, T.K.4
Der, C.J.5
-
10
-
-
0027304731
-
Human Sos1: a guanine nucleotide exchange factor for Ras that binds to GRB2
-
Chardin, P., J.H. Camonis, N.W. Gale, L. van Aelst, J. Schlessinger, M.H. Wigler, and D. Bar-Sagi. 1993. Human Sos1: a guanine nucleotide exchange factor for Ras that binds to GRB2. Science. 260:1338-1343. http://dx.doi.org/10.1126/science.8493579
-
(1993)
Science.
, vol.260
, pp. 1338-1343
-
-
Chardin, P.1
Camonis, J.H.2
Gale, N.W.3
van Aelst, L.4
Schlessinger, J.5
Wigler, M.H.6
Bar-Sagi, D.7
-
11
-
-
33746217416
-
Discovery of a novel shp2 protein tyrosine phosphatase inhibitor
-
Chen, L., S.S. Sung, M.L.R. Yip, H.R. Lawrence, Y. Ren, W.C. Guida, S.M. Sebti, N.J. Lawrence, and J. Wu. 2006. Discovery of a novel shp2 protein tyrosine phosphatase inhibitor. Mol. Pharmacol. 70:562-570. http://dx.doi.org/10.1124/mol.106.025536
-
(2006)
Mol. Pharmacol.
, vol.70
, pp. 562-570
-
-
Chen, L.1
Sung, S.S.2
Yip, M.L.R.3
Lawrence, H.R.4
Ren, Y.5
Guida, W.C.6
Sebti, S.M.7
Lawrence, N.J.8
Wu, J.9
-
12
-
-
47249122523
-
Drug-sensitive FGFR2 mutations in endometrial carcinoma
-
Dutt, A., H.B. Salvesen, T.H. Chen, A.H. Ramos, R.C. Onofrio, C. Hatton, R. Nicoletti, W. Winckler, R. Grewal, M. Hanna, et al. 2008. Drug-sensitive FGFR2 mutations in endometrial carcinoma. Proc. Natl. Acad. Sci. USA. 195:8713-8717. http://dx.doi.org/10.1073/pnas.0803379105
-
(2008)
Proc. Natl. Acad. Sci. USA.
, vol.105
, pp. 8713-8717
-
-
Dutt, A.1
Salvesen, H.B.2
Chen, T.H.3
Ramos, A.H.4
Onofrio, R.C.5
Hatton, C.6
Nicoletti, R.7
Winckler, W.8
Grewal, R.9
Hanna, M.10
-
13
-
-
0027531637
-
SH2-containing phosphotyrosine phosphatase as a target of protein-tyrosine kinases
-
Feng, G.S., C.C. Hui, and T. Pawson. 1993. SH2-containing phosphotyrosine phosphatase as a target of protein-tyrosine kinases. Science. 259:1607-1611. http://dx.doi.org/10.1126/science.8096088
-
(1993)
Science.
, vol.259
, pp. 1607-1611
-
-
Feng, G.S.1
Hui, C.C.2
Pawson, T.3
-
14
-
-
0026471539
-
Identification of a human src homology 2-containing protein-tyrosine-phosphatase: a putative homolog of Drosophila corkscrew
-
Freeman, R.M. Jr., J. Plutzky, and B.G. Neel. 1992. Identification of a human src homology 2-containing protein-tyrosine-phosphatase: a putative homolog of Drosophila corkscrew. Proc. Natl. Acad. Sci. USA. 89:11239-11243. http://dx.doi.org/10.1073/pnas.89.23.11239
-
(1992)
Proc. Natl. Acad. Sci. USA.
, vol.89
, pp. 11239-11243
-
-
Freeman Jr., R.M.1
Plutzky, J.2
Neel, B.G.3
-
15
-
-
0141885098
-
Conditional activation of fibroblast growth factor receptor (FGFR) 1, but not FGFR2, in prostate cancer cells leads to increased osteopontin induction, extracellular signal-regulated kinase activation, and in vivo proliferation
-
Freeman, K.W., R.D. Gangula, B.E. Welm, M. Ozen, B.A. Foster, J.M. Rosen, M. Ittmann, N.M. Greenberg, and D.M. Spencer. 2003. Conditional activation of fibroblast growth factor receptor (FGFR) 1, but not FGFR2, in prostate cancer cells leads to increased osteopontin induction, extracellular signal-regulated kinase activation, and in vivo proliferation. Cancer Res. 63:6237-6243.
-
(2003)
Cancer Res.
, vol.63
, pp. 6237-6243
-
-
Freeman, K.W.1
Gangula, R.D.2
Welm, B.E.3
Ozen, M.4
Foster, B.A.5
Rosen, J.M.6
Ittmann, M.7
Greenberg, N.M.8
Spencer, D.M.9
-
16
-
-
58749107496
-
Loss-of-function fibroblast growth factor receptor-2 mutations in melanoma
-
Gartside, M.G., H. Chen, O.A. Ibrahimi, S.A. Byron, A.V. Curtis, C.L. Wellens, A. Bengston, L.M. Yudt, A.V. Eliseenkova, J. Ma, et al. 2009. Loss-of-function fibroblast growth factor receptor-2 mutations in melanoma. Mol. Cancer Res. 7:41-54. http://dx.doi.org/10.1158/1541-7786.MCR-08-0021
-
(2009)
Mol. Cancer Res.
, vol.7
, pp. 41-54
-
-
Gartside, M.G.1
Chen, H.2
Ibrahimi, O.A.3
Byron, S.A.4
Curtis, A.V.5
Wellens, C.L.6
Bengston, A.7
Yudt, L.M.8
Eliseenkova, A.V.9
Ma, J.10
-
17
-
-
77955293912
-
Germline and somatic mosaicism for FGFR2 mutation in the mother of a child with Crouzon syndrome: Implications for genetic testing in "paternal age-effect" syndromes
-
Goriely, A., H. Lord, J. Lim, D. Johnson, T. Lester, H.V. Firth, and A.O. Wilkie. 2010. Germline and somatic mosaicism for FGFR2 mutation in the mother of a child with Crouzon syndrome: Implications for genetic testing in "paternal age-effect" syndromes. Am. J. Med. Genet. A. 152A:2067-2073. http://dx.doi.org/10.1002/ajmg.a.33513
-
(2010)
Am. J. Med. Genet. A.
, vol.152 A
, pp. 2067-2073
-
-
Goriely, A.1
Lord, H.2
Lim, J.3
Johnson, D.4
Lester, T.5
Firth, H.V.6
Wilkie, A.O.7
-
18
-
-
77954638588
-
The tyrosine phosphatase Shp2 in development and cancer
-
Grossmann, K.S., M. Rosário, C. Birchmeier, and W. Birchmeier. 2010. The tyrosine phosphatase Shp2 in development and cancer. Adv. Cancer Res. 196:53-89. http://dx.doi.org/10.1016/S0065-230X(10)06002-1
-
(2010)
Adv. Cancer Res.
, vol.106
, pp. 53-89
-
-
Grossmann, K.S.1
Rosário, M.2
Birchmeier, C.3
Birchmeier, W.4
-
19
-
-
0031835659
-
Binding of Shp2 tyrosine phosphatase to FRS2 is essential for fibroblast growth factorinduced PC12 cell differentiation
-
Hadari, Y.R., H. Kouhara, I. Lax, and J. Schlessinger. 1998. Binding of Shp2 tyrosine phosphatase to FRS2 is essential for fibroblast growth factorinduced PC12 cell differentiation. Mol. Cell. Biol. 18:3966-3973.
-
(1998)
Mol. Cell. Biol.
, vol.18
, pp. 3966-3973
-
-
Hadari, Y.R.1
Kouhara, H.2
Lax, I.3
Schlessinger, J.4
-
20
-
-
0025365350
-
K-sam, an amplified gene in stomach cancer, is a member of the heparin-binding growth factor receptor genes
-
Hattori, Y., H. Odagiri, H. Nakatani, K. Miyagawa, K. Naito, H. Sakamoto, O. Katoh, T. Yoshida, T. Sugimura, and M. Terada. 1990. K-sam, an amplified gene in stomach cancer, is a member of the heparin-binding growth factor receptor genes. Proc. Natl. Acad. Sci. USA. 87:5983-5987. http://dx.doi.org/10.1073/pnas.87.15.5983
-
(1990)
Proc. Natl. Acad. Sci. USA.
, vol.87
, pp. 5983-5987
-
-
Hattori, Y.1
Odagiri, H.2
Nakatani, H.3
Miyagawa, K.4
Naito, K.5
Sakamoto, H.6
Katoh, O.7
Yoshida, T.8
Sugimura, T.9
Terada, M.10
-
21
-
-
9544251380
-
Immunohistochemical detection of K-sam protein in stomach cancer
-
Hattori, Y., H. Itoh, S. Uchino, K. Hosokawa, A. Ochiai, Y. Ino, H. Ishii, H. Sakamoto, N. Yamaguchi, K. Yanagihara, et al. 1996. Immunohistochemical detection of K-sam protein in stomach cancer. Clin. Cancer Res. 2:1373-1381.
-
(1996)
Clin. Cancer Res.
, vol.2
, pp. 1373-1381
-
-
Hattori, Y.1
Itoh, H.2
Uchino, S.3
Hosokawa, K.4
Ochiai, A.5
Ino, Y.6
Ishii, H.7
Sakamoto, H.8
Yamaguchi, N.9
Yanagihara, K.10
-
22
-
-
0032548830
-
Crystal structure of the tyrosine phosphatase SHP-2
-
Hof, P., S. Pluskey, S. Dhe-Paganon, M.J. Eck, and S.E. Shoelson. 1998. Crystal structure of the tyrosine phosphatase SHP-2. Cell. 92:441-450. http://dx.doi.org/10.1016/S0092-8674(00)80938-1
-
(1998)
Cell.
, vol.92
, pp. 441-450
-
-
Hof, P.1
Pluskey, S.2
Dhe-Paganon, S.3
Eck, M.J.4
Shoelson, S.E.5
-
23
-
-
0030028790
-
A Grb2-associated docking protein in EGF-and insulinreceptor signalling
-
Holgado-Madruga, M., D.R. Emlet, D.K. Moscatello, A.K. Godwin, and A.J. Wong. 1996. A Grb2-associated docking protein in EGF-and insulinreceptor signalling. Nature. 379:560-564. http://dx.doi.org/10.1038/379560a0
-
(1996)
Nature.
, vol.379
, pp. 560-564
-
-
Holgado-Madruga, M.1
Emlet, D.R.2
Moscatello, D.K.3
Godwin, A.K.4
Wong, A.J.5
-
24
-
-
0029012406
-
A truncated K-sam product lacking the distal carboxyl-terminal portion provides a reduced level of autophosphorylation and greater resistance against induction of differentiation
-
Ishii, H., T. Yoshida, H. Oh, S. Yoshida, and M. Terada. 1995. A truncated K-sam product lacking the distal carboxyl-terminal portion provides a reduced level of autophosphorylation and greater resistance against induction of differentiation. Mol. Cell. Biol. 15:3664-3671.
-
(1995)
Mol. Cell. Biol.
, vol.15
, pp. 3664-3671
-
-
Ishii, H.1
Yoshida, T.2
Oh, H.3
Yoshida, S.4
Terada, M.5
-
25
-
-
0028305121
-
Preferential alternative splicing in cancer generates a K-sam messenger RNA with higher transforming activity
-
Itoh, H., Y. Hattori, H. Sakamoto, H. Ishii, T. Kishi, H. Sasaki, T. Yoshida, M. Koono, T. Sugimura, and M. Terada. 1994. Preferential alternative splicing in cancer generates a K-sam messenger RNA with higher transforming activity. Cancer Res. 54:3237-3241.
-
(1994)
Cancer Res.
, vol.54
, pp. 3237-3241
-
-
Itoh, H.1
Hattori, Y.2
Sakamoto, H.3
Ishii, H.4
Kishi, T.5
Sasaki, H.6
Yoshida, T.7
Koono, M.8
Sugimura, T.9
Terada, M.10
-
26
-
-
0035328856
-
Mutations in fibroblast growth factor receptor 2 and fibroblast growth factor receptor 3 genes associated with human gastric and colorectal cancers
-
Jang, J.H., K.H. Shin, and J.G. Park. 2001. Mutations in fibroblast growth factor receptor 2 and fibroblast growth factor receptor 3 genes associated with human gastric and colorectal cancers. Cancer Res. 61:3541-3543.
-
(2001)
Cancer Res.
, vol.61
, pp. 3541-3543
-
-
Jang, J.H.1
Shin, K.H.2
Park, J.G.3
-
27
-
-
0033870788
-
A novel mutation, Ala315Ser, in FGFR2: a gene-environment interaction leading to craniosynostosis?
-
Johnson, D., S.A. Wall, S. Mann, and A.O. Wilkie. 2000. A novel mutation, Ala315Ser, in FGFR2: a gene-environment interaction leading to craniosynostosis? Eur. J. Hum. Genet. 8:571-577. http://dx.doi.org/10.1038/sj.ejhg.5200499
-
(2000)
Eur. J. Hum. Genet.
, vol.8
, pp. 571-577
-
-
Johnson, D.1
Wall, S.A.2
Mann, S.3
Wilkie, A.O.4
-
28
-
-
24744465207
-
Diverse biochemical properties of Shp2 mutants
-
Keilhack, H., F.S. David, M. McGregor, L.C. Cantley, and B.G. Neel. 2005. Diverse biochemical properties of Shp2 mutants. Implications for disease phenotypes. J. Biol. Chem. 280:30984-30993. http://dx.doi.org/10.1074/jbc.M504699200
-
(2005)
Implications for disease phenotypes. J. Biol. Chem.
, vol.280
, pp. 30984-30993
-
-
Keilhack, H.1
David, F.S.2
McGregor, M.3
Cantley, L.C.4
Neel, B.G.5
-
29
-
-
80052211582
-
Rapid phospho-turnover by receptor tyrosine kinases impacts downstream signaling and drug binding
-
Kleiman, L.B., T. Maiwald, H. Conzelmann, D.A. Lauffenburger, and P.K. Sorger. 2011. Rapid phospho-turnover by receptor tyrosine kinases impacts downstream signaling and drug binding. Mol. Cell. 43:723-737. http://dx.doi.org/10.1016/j.molcel.2011.07.014
-
(2011)
Mol. Cell.
, vol.43
, pp. 723-737
-
-
Kleiman, L.B.1
Maiwald, T.2
Conzelmann, H.3
Lauffenburger, D.A.4
Sorger, P.K.5
-
30
-
-
0033965233
-
Basic fibroblast growth factor confers a less malignant phenotype in MDA-MB-231 human breast cancer cells
-
Korah, R.M., V. Sysounthone, Y. Golowa, and R. Wieder. 2000. Basic fibroblast growth factor confers a less malignant phenotype in MDA-MB-231 human breast cancer cells. Cancer Res. 60:733-740.
-
(2000)
Cancer Res.
, vol.60
, pp. 733-740
-
-
Korah, R.M.1
Sysounthone, V.2
Golowa, Y.3
Wieder, R.4
-
31
-
-
0030706168
-
A lipid-anchored Grb2-binding protein that links FGF-receptor activation to the Ras/MAPK signaling pathway
-
Kouhara, H., Y.R. Hadari, T. Spivak-Kroizman, J. Schilling, D. Bar-Sagi, I. Lax, and J. Schlessinger. 1997. A lipid-anchored Grb2-binding protein that links FGF-receptor activation to the Ras/MAPK signaling pathway. Cell. 89:693-702. http://dx.doi.org/10.1016/S0092-8674(00)80252-4
-
(1997)
Cell.
, vol.89
, pp. 693-702
-
-
Kouhara, H.1
Hadari, Y.R.2
Spivak-Kroizman, T.3
Schilling, J.4
Bar-Sagi, D.5
Lax, I.6
Schlessinger, J.7
-
32
-
-
84862669198
-
Inhibition of basal FGF receptor signaling by dimeric Grb2
-
Lin, C.-C., F.A. Melo, R. Ghosh, K.M. Suen, L.J. Stagg, J. Kirkpatrick, S.T. Arold, Z. Ahmed, and J.E. Ladbury. 2012. Inhibition of basal FGF receptor signaling by dimeric Grb2. Cell. 149:1514-1524. http://dx.doi.org/10.1016/j.cell.2012.04.033
-
(2012)
Cell.
, vol.149
, pp. 1514-1524
-
-
Lin, C.-C.1
Melo, F.A.2
Ghosh, R.3
Suen, K.M.4
Stagg, L.J.5
Kirkpatrick, J.6
Arold, S.T.7
Ahmed, Z.8
Ladbury, J.E.9
-
33
-
-
0026729382
-
The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling
-
Lowenstein, E.J., R.J. Daly, A.G. Batzer, W. Li, B. Margolis, R. Lammers, A. Ullrich, E.Y. Skolnik, D. Bar-Sagi, and J. Schlessinger. 1992. The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling. Cell. 70:431-442. http://dx.doi.org/10.1016/0092-8674(92)90167-B
-
(1992)
Cell.
, vol.70
, pp. 431-442
-
-
Lowenstein, E.J.1
Daly, R.J.2
Batzer, A.G.3
Li, W.4
Margolis, B.5
Lammers, R.6
Ullrich, A.7
Skolnik, E.Y.8
Bar-Sagi, D.9
Schlessinger, J.10
-
34
-
-
0034758469
-
Site-specific incorporation of a phosphotyrosine mimetic reveals a role for tyrosine phosphorylation of SHP-2 in cell signaling
-
Lu, W., D. Gong, D. Bar-Sagi, and P.A. Cole. 2001. Site-specific incorporation of a phosphotyrosine mimetic reveals a role for tyrosine phosphorylation of SHP-2 in cell signaling. Mol. Cell. 8:759-769. http://dx.doi.org/10.1016/S1097-2765(01)00369-0
-
(2001)
Mol. Cell.
, vol.8
, pp. 759-769
-
-
Lu, W.1
Gong, D.2
Bar-Sagi, D.3
Cole, P.A.4
-
36
-
-
0037665155
-
Specificity is complex and time consuming: mutual exclusivity in tyrosine kinase-mediated signaling
-
O'Rourke, L., and J.E. Ladbury. 2003. Specificity is complex and time consuming: mutual exclusivity in tyrosine kinase-mediated signaling. Acc. Chem. Res. 36:410-416. http://dx.doi.org/10.1021/ar020167s
-
(2003)
Acc. Chem. Res.
, vol.36
, pp. 410-416
-
-
O'Rourke, L.1
Ladbury, J.E.2
-
37
-
-
34250829395
-
Frequent activating FGFR2 mutations in endometrial carcinomas parallel germline mutations associated with craniosynostosis and skeletal dysplasia syndromes
-
Pollock, P.M., M.G. Gartside, L.C. Dejeza, M.A. Powell, M.A. Mallon, H. Davies, M. Mohammadi, P.A. Futreal, M.R. Stratton, J.M. Trent, and P.J. Goodfellow. 2007. Frequent activating FGFR2 mutations in endometrial carcinomas parallel germline mutations associated with craniosynostosis and skeletal dysplasia syndromes. Oncogene. 26:7158-7162. http://dx.doi.org/10.1038/sj.onc.1210529
-
(2007)
Oncogene.
, vol.26
, pp. 7158-7162
-
-
Pollock, P.M.1
Gartside, M.G.2
Dejeza, L.C.3
Powell, M.A.4
Mallon, M.A.5
Davies, H.6
Mohammadi, M.7
Futreal, P.A.8
Stratton, M.R.9
Trent, J.M.10
Goodfellow, P.J.11
-
38
-
-
0027294981
-
The SH2 and SH3 domains of mammalian Grb2 couple the EGF receptor to the Ras activator mSos1
-
Rozakis-Adcock, M., R. Fernley, J. Wade, T. Pawson, and D. Bowtell. 1993. The SH2 and SH3 domains of mammalian Grb2 couple the EGF receptor to the Ras activator mSos1. Nature. 363:83-85. http://dx.doi.org/10.1038/363083a0
-
(1993)
Nature.
, vol.363
, pp. 83-85
-
-
Rozakis-Adcock, M.1
Fernley, R.2
Wade, J.3
Pawson, T.4
Bowtell, D.5
-
39
-
-
77958114168
-
FRS2α regulates Erk levels to control a self-renewal target Hes1 and proliferation of FGF-responsive neural stem/progenitor cells
-
Sato, T., T. Shimazaki, H. Naka, S. Fukami, Y. Satoh, H. Okano, I. Lax, J. Schlessinger, and N. Gotoh. 2010. FRS2α regulates Erk levels to control a self-renewal target Hes1 and proliferation of FGF-responsive neural stem/progenitor cells. Stem Cells. 28:1661-1673. http://dx.doi.org/10.1002/stem.488
-
(2010)
Stem Cells.
, vol.28
, pp. 1661-1673
-
-
Sato, T.1
Shimazaki, T.2
Naka, H.3
Fukami, S.4
Satoh, Y.5
Okano, H.6
Lax, I.7
Schlessinger, J.8
Gotoh, N.9
-
40
-
-
39749113704
-
Extracellular point mutations in FGFR2 result in elevated ERK1/2 activation and perturbation of neuronal differentiation
-
Schüller, A.C., Z. Ahmed, and J.E. Ladbury. 2008. Extracellular point mutations in FGFR2 result in elevated ERK1/2 activation and perturbation of neuronal differentiation. Biochem. J. 410:205-211. http://dx.doi.org/10.1042/BJ20070859
-
(2008)
Biochem. J.
, vol.410
, pp. 205-211
-
-
Schüller, A.C.1
Ahmed, Z.2
Ladbury, J.E.3
-
41
-
-
75149170979
-
Fibroblast growth factor signalling: from development to cancer
-
Turner, N., and R. Grose. 2010. Fibroblast growth factor signalling: from development to cancer. Nat. Rev. Cancer. 19:116-129. http://dx.doi.org/10.1038/nrc2780
-
(2010)
Nat. Rev. Cancer.
, vol.10
, pp. 116-129
-
-
Turner, N.1
Grose, R.2
-
42
-
-
0028798546
-
Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome
-
Wilkie, A.O., S.F. Slaney, M. Oldridge, M.D. Poole, G.J. Ashworth, A.D. Hockley, R.D. Hayward, D.J. David, L.J. Pulleyn, P. Rutland, et al. 1995. Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome. Nat. Genet. 9:165-172. http://dx.doi.org/10.1038/ng0295-165
-
(1995)
Nat. Genet.
, vol.9
, pp. 165-172
-
-
Wilkie, A.O.1
Slaney, S.F.2
Oldridge, M.3
Poole, M.D.4
Ashworth, G.J.5
Hockley, A.D.6
Hayward, R.D.7
David, D.J.8
Pulleyn, L.J.9
Rutland, P.10
-
43
-
-
34247871298
-
Distinct roles of fibroblast growth factor receptor 1 and 2 in regulating cell survival and epithelialmesenchymal transition
-
Xian, W., K.L. Schwertfeger, and J.M. Rosen. 2007. Distinct roles of fibroblast growth factor receptor 1 and 2 in regulating cell survival and epithelialmesenchymal transition. Mol. Endocrinol. 21:987-1000. http://dx.doi.org/10.1210/me.2006-0518
-
(2007)
Mol. Endocrinol.
, vol.21
, pp. 987-1000
-
-
Xian, W.1
Schwertfeger, K.L.2
Rosen, J.M.3
-
44
-
-
0034687699
-
Loss of fibroblast growth factor receptor 2 ligand-binding specificity in Apert syndrome
-
Yu, K., A.B. Herr, G. Waksman, and D.M. Ornitz. 2000. Loss of fibroblast growth factor receptor 2 ligand-binding specificity in Apert syndrome. Proc. Natl. Acad. Sci. USA. 97:14536-14541. http://dx.doi.org/10.1073/pnas.97.26.14536
-
(2000)
Proc. Natl. Acad. Sci. USA.
, vol.97
, pp. 14536-14541
-
-
Yu, K.1
Herr, A.B.2
Waksman, G.3
Ornitz, D.M.4
|